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HISTOPATHOLOGICAL ASSESSMENT OF ASTROGLIAL AQUAPORIN-4 
EXPRESSION IN CHRONIC TRAUMATIC ENCEPHALOPATHY   
KATHARINE BABCOCK 
ABSTRACT  
 
BACKGROUND: The accumulation of misfolded proteins is a hallmark of many 
neurodegenerative disorders, including Chronic Traumatic Encephalopathy (CTE). 
Intracellular protein degradation pathways appear to be insufficient in preventing or 
halting disease progression. A brain-wide waste clearance pathway mediated by astroglial 
aquaporin-4 (AQP4) water channels in the perivascular space called the “glymphatic 
system” has recently been identified. Disruption of this system due to mislocalization of 
AQP4 away from perivascular astrocytic endfeet (“depolarization”) is linked to 
reductions in solute clearance and the build up of toxic metabolites in different 
neurologic conditions associated with aging and traumatic brain injury. Accumulation of 
aggregated tau protein around blood vessels at the depths of cortical sulci is considered 
the pathognomonic lesion of CTE, and may reflect impairment of glymphatic pathway 
function in these perivascular spaces.  
OBJECTIVES: To investigate whether changes in AQP4 expression or perivascular 
AQP4 polarization are present in CTE and to assess their relationship with CTE lesions. 
Additionally, AQP4 expression in CTE will be compared to subjects with a pathological 
diagnosis of Alzheimer’s disease (AD) and non-pathological controls without a history of 
head trauma.  
		 vii 
METHODS: Postmortem frontal cortex samples from neuropatholigcally confirmed 
cases of CTE, AD, and non-pathological controls were provided by the VA-BU-CLF 
Brain Bank. Fixed tissue samples were cut at 20 microns from each case and 
immunofluorescently stained for AQP4, glial fibrillary acidic protein (GFAP), and 
phosphorylated tau (AT-8). Slides were imaged using a Zeiss 880 Airyscan confocal 
microscope and analyzed using the HALO image software analysis platform.  
RESULTS: Increased perivascular AQP4 polarization was significantly associated with 
lesional vessels compared to non-lesional vessels in CTE (p=0.0187).  When assessed 
between groups, CTE showed less AQP4 polarization surrounding non-lesional vessels 
compared to controls, and seemingly higher polarization around lesional vessels 
compared to AD, however these differences were not statistically significant.  
CONCLUSIONS: Blood brain barrier (BBB) breakdown is a common occurrence 
following traumatic brain injury (TBI) and has previously been confirmed in postmortem 
cases of CTE. The findings reported in the current study showing increased, rather than 
decreased, perivascular AQP4 polarization around lesional vessels compared to non-
lesional vessels in CTE may therefore reflect a compensatory mechanism of astrocytes in 
response to secondary vasogenic edema in the face of chronic inflammation and 
disrupted BBB integrity, rather than acute cytotoxic edema which is likely the main 
driver of AQP4 depolarization reported in previous studies. 
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INTRODUCTION 
 
 
The accumulation of misfolded proteins is a hallmark of many neurodegenerative 
disorders, including Chronic Traumatic Encephalopathy (CTE). Intracellular protein 
degradation pathways appear to be insufficient in preventing or halting disease 
progression. A brain-wide waste clearance pathway mediated by astroglial aquaporin-4 
(AQP4) water channels in the perivascular space called the “glymphatic system” has 
recently been identified (Iliff et al., 2012). Disruption of this system due to 
mislocalization of AQP4 away from perivascular astrocytic endfeet (“depolarization”) is 
linked to reductions in solute clearance and the build up of toxic metabolites in different 
neurologic conditions associated with aging and traumatic brain injury (Ren et al., 2013, 
Kress et al. 2014). Accumulation of aggregated tau protein around blood vessels at the 
depths of cortical sulci is considered the pathognomonic lesion of CTE, and may reflect 
impairment of glymphatic pathway function in these perivascular spaces.   
 
Chronic Traumatic Encephalopathy Background 
Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative 
disorder linked to a history of repetitive head trauma (McKee et al., 2013). The majority 
of people diagnosed with CTE have a history of playing tackle sports, including 
American football, boxing, rugby, hockey, and soccer, or a history of military history of 
blast exposure (McKee et al., 2013). Like other neurodegenerative diseases, CTE can 
only be diagnosed post-mortem through a neuropathological exam. 
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CTE belongs to a class of neurodegenerative disorders known as tauopathies 
characterized by the abnormal accumulation of hyperphosphorylated tau protein. 
However CTE is distinct from other tauopathies, such as Alzheimer’s Disease (AD), 
because of its unique pattern of tau deposition (McKee et al., 2013). In 2015 a panel of 
neuropathologists convened to establish diagnostic criteria for the disease and concluded 
the pathognomonic lesion of CTE to be “an accumulation of abnormal 
hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood 
vessels at the depths of cortical sulci and in an irregular pattern (Figure 1, McKee et al., 
2016).” 
 
 
Figure 1. Pathognomonic CTE Lesion. A microscopic image illustrating the 
histopathological hallmark of CTE involving the perivascular accumulation of p-tau 
(McKee et al., 2016).  
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Tau is a normal protein found in neurons that helps give structural support to 
microtubules in the cellular cytoskeleton, most notably in the axons (Ling, 2018). Some 
speculate that head trauma triggers the initial release of tau from its normal position in 
the axonal cytoskeleton, which then begins to accrue in somatodendritic compartments 
ultimately leading to neurofibrillary tangle (NFT) formation (Geddes et al., 1999). 
However the precise mechanisms driving the accumulation of tau and disease progression 
following repetitive head trauma in CTE are still largely unknown.   
 
Traditional Brain Waste Clearance Pathways  
 The brain is one of the most metabolically active organs in the human body 
(Herculano-Houzel, 2011), requiring a constant supply of energy and an impeccably 
homeostatic environment to function properly. The highly active nature of the brain 
results in a significant amount of waste, in the form of metabolites and other protein 
byproducts, to be released into the interstitial fluid (ISF) between cells (Yamada et al., 
2014). Failure to cleanse the ISF of these excess solutes can lead to perturbations in the 
extracellular environment that impair the normal functioning of brain cells and may 
ultimately lead to cell death (Iliff et al., 2014). Indeed, most neurodegenerative diseases 
are classified on the basis of aberrant protein accumulation in either the intracellular (e.g. 
neurofibrillary tangles), or extracellular (e.g. amyloid-beta plaques) compartments 
(Taylor et al., 2002).  
There are a growing number of ways the brain is thought to cope with the build up 
of interstitial solutes in order to maintain homeostatic conditions for normal brain 
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function. So-called “protein quality control systems”, including the autophagy-lysosome 
and ubiquitin-proteosome pathways, involve tagging and sequestration of misfolded 
proteins prior to intracellular degradation (Naiki et al., 2009). Other means of waste 
removal include efflux across the blood brain barrier, such as the transcytosis of amyloid-
beta by the low-density lipoprotein receptor-related protein-1 (LRP1) transporter 
(Zlokovic et al., 2010). Nevertheless these pathways appear to be insufficient in 
preventing the accumulation of misfolded proteins characteristic of the brain in aging and 
disease. 
 
Glymphatic System Background 
 An alternative brain waste clearance mechanism mediated by cerebrospinal fluid 
(CSF) circulation within paravascular channels has recently been defined (Iliff et al., 
2012). CSF is produced by choroid plexus epithelial cells and travels through the 
ventricular system before exiting through the fourth ventricle into the subarachnoid space 
to bathe and cushion the brain (Iliff et al., 2012). CSF then re-enters the brain along 
penetrating arteries, traveling within the perivascular space (PVS) bordered on the 
abluminal side by blood vessel endothelial cells and on the parenchymal side by 
perivascular astrocytic endfoot processes (Jessen et al., 2015). Driven by convective flow 
mediated by cardiac pulsatility, CSF exits the PVS and enters the surrounding tissue 
where it exchanges with ISF and helps drive the clearance of interstitial solutes into 
perivenous spaces (Rennels et al., 1990).  
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In a study using two photon imaging and fluorescently labeled CSF tracers in live 
mice, Iliff et al. confirmed the role of CSF-ISF exchange in interstitial solute clearance, 
including amyloid-beta (Aβ) (Iliff et al., 2012). It also highlighted the key role of the 
astroglial aquaporin-4 (AQP4) water channel in this system by showing that AQP4 
knockout mice had 65% less CSF influx and up to 55% less Aβ clearance relative to 
controls. Similar findings were reported in a study of aging mice (Kress et al., 2014). 
This pathway, outlined in Figure 2, was aptly named the “glymphatic system” due to its 
reliance on astroglial water channels and its functional similarities to the peripheral 
lymphatic system.  
 
 
Figure 2. Schematic of the Glymphatic System. This image illustrates the influx of 
cerebrospinal fluid (CSF) mediated by convective flow into the perivascular space (PVS) 
of penetrating arteries. Aquaporin-4 (AQP4) water channels enriched at perivascular 
astrocytic endfeet line the outside of the PVS and facilitate the influx of CSF into 
surrounding brain tissue. Influx of CSF into the parenchyma drives the efflux of waste 
products in the interstitial fluid (ISF) into the PVS of nearby veins which ultimately drain 
to peripheral lymphatic vessels (Nedergaard, 2013).  
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Under normal physiological conditions AQP4 is predominantly expressed in 
astrocytes, most notably in their endfeet processes abutting the brain vasculature (Potokar 
et al., 2016). This perivascular “polarization” of AQP4 facilitates the transport of water 
across cell membranes in an effort to maintain brain water homeostasis (Verkman et al., 
2000). A growing number of studies report mislocalization (“depolarization”) of AQP4 
away from astrocytic endfeet in a number of different pathological settings, including 
vascular disease (Wang et al., 2012, Mestre et al., 2017), aging (Kress et al., 2014), and 
Alzheimer’s disease (Zeppenfield et al., 2017). These studies suggest that the 
accumulation of toxic proteins seen in most, if not all, neurodegenerative disorders, and 
to some degree normal aging, may occur due to disrupted glymphatic system waste 
clearance abilities mediated by a loss of perivascular AQP4.  
Reductions in AQP4 polarization have also been reported in animal models of 
traumatic brain injury (TBI) (Ren et al., 2013, Iliff et al., 2014). Furthermore, these post-
traumatic AQP4 alterations were associated with reduced glymphatic pathway function 
and accumulation of tau pathology. Meanwhile, studies assessing age-related changes in 
AQP4 localization found glymphatic function is also reduced in aging mice (Kress et al., 
2014). Notably, these age-related effects on AQP4 expression were recently corroborated 
in a post-mortem study of human brain tissue (Zeppenfield et al., 2017). The same study 
also examined Alzheimer’s disease and found AQP4 expression was significantly 
increased overall, but significantly decreased within perivascular astrocytic endfeet 
compared to normal aging. Furthermore, the study reported these reductions in AQP4 
polarization were significantly associated with increased Aβ burden and cognitive decline 
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(Zeppenfield et al., 2017), providing further support to the role of AQP4 in glymphatic 
system function.  
The known alterations of AQP4 expression and resultant metabolite buildup in 
age-related diseases and following trauma suggests the accumulation of p-tau around 
blood vessels in CTE may also reflect impairment of glymphatic pathway function. The 
aim of the present study is therefore to investigate whether changes in AQP4 expression 
or perivascular AQP4 polarization are present in CTE and to assess their relationship 
with CTE p-tau lesions. Additionally, AQP4 expression in CTE will be compared to 
subjects with a pathological diagnosis of Alzheimer’s disease and non-pathological 
controls without a history of head trauma. Altered expression of AQP4 in CTE tissue 
would support previous studies and implicate disruption of astroglial perivascular waste 
clearance abilities as a potential new contributor to CTE pathogenesis following 
repetitive head trauma. 
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METHODS 
 
Subjects 
All subjects were divided into one of three groups based on their 
neuropathological diagnosis as outlined in Table 1:  
1. “Pure” CTE=without any co-morbid diseases, further subdivided by CTE 
stage 
2. Alzheimer’s Disease (Braak & Braak Stage V-VI)  
3. Non-Pathological Control without a history of repetitive head injury 
 
Table 1. Study Subject Demographics  
Group Sample Size (n) Mean Age History of RHI 
CTE Stage I-II 2 51.5 Yes 
CTE Stage II 5 57.8 Yes 
CTE Stage III 5 59.8 Yes 
CTE Stage IV 4 77.8 Yes 
AD 4 73.25 No 
Control 4 71 No 
 
Tissue Acquisition 
Post-mortem brain tissue samples harvested from the frontal cortex of each 
subject were embedded in paraffin and cut at 20 µms. Cut paraffin sections were 
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transferred to a hot water bath and picked up on charged glass microscope slides then left 
to air dry in an upright position overnight. Slides were baked at 65 degrees Celsius for at 
least one hour the next day and stored for later use.  
 
Immunohistochemistry  
Primary antibodies used in this study included Aquaporin 4 (rabbit anti-AQP4, 
AB3594-200UL, Millipore, Billerica, MA, 1:500), the astrocytic marker Glial fibrillary 
acidic protein (chicken anti-GFAP, Abcam #ab106582, 1:2,000), and Phospho-Tau 
(mouse anti-AT8, MN102B, Thermo Fisher Scientific, Cambridge, MA, 1:500). Prior to 
immunofluorescence, each primary antibody was first optimized for 
immunohistochemical staining on a Leica Bond RX automated tissue stainer.  
 
Multiplex Immunofluorescence  
Following optimization for immunohistochemistry, each primary antibody was 
optimized individually for immufluorescence on the Bond. Tissue sections were stained 
on an automated tissue stainer (Leica Bond RX) using custom-built protocols for 
multiplex immunofluorescence (software v5.2 or higher) specific to the markers of 
interest in the present study. 150 microliters of each reagent solution were dispensed per 
slide. Slides were pre-treated with a series of four dewax steps, followed by a series of 
alcohols (x3) and bond wash (x3) rinses.  
Slides were heated to 95 degrees Celsius and incubated for 20 minutes with ER 
Solution 1 to undergo antigen retrieval for the first primary antibody (AQP4). Slides were 
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rinsed in bond wash (6x) and incubated with 3% Peroxide Block for 10 minutes to block. 
Slides were rinsed in bond wash (x2) and incubated with 3% normal donkey serum in 
phosphate buffered saline and 0.1% Triton X-100 (DKS Block) at room temperature for 
30 minutes. Slides were incubated for 60 minutes at room temperature with the first 
primary antibody, Aquaporin 4 (rabbit anti-AQP4, AB3594-200UL, Millipore, Billerica, 
MA, 1:500), diluted in 1% normal donkey serum in phosphate buffered saline and 0.1% 
Triton X-100. Slides were rinsed (3x) and incubated with a horseradish peroxidase 
(HRP)-conjugated rabbit secondary antibody for 30 minutes at room temperature, then 
rinsed (5x) again and incubated with the first fluorescent Tyramide Signal Amplification 
reagent, Opal 520, for 15 minutes at room temperature. Slides were rinsed again (4x) 
prior to the next step.  
Slides were incubated with ER Solution 1 for 20 minutes at 95 degrees Celsius to 
undergo antigen retrieval for the second primary antibody (AT8), then rinsed in bond 
wash (x2) and incubated with 3% normal donkey serum in phosphate buffered saline and 
0.1% Triton X-100 (DKS Block) at room temperature for 30 minutes. Slides were 
incubated for 60 minutes at room temperature with the second primary antibody, 
Phospho-Tau (mouse anti-AT8, MN102B, Thermo Fisher Scientific, Cambridge, MA, 
1:500), diluted in 1% normal donkey serum in phosphate buffered saline and 0.1% Triton 
X-100. After an hour, slides were rinsed briefly in bond wash (3x) before incubation with 
a horseradish peroxidase (HRP)-conjugated mouse secondary antibody for 30 minutes at 
room temperature. Slides were then rinsed (5x) and incubated with the second fluorescent 
	11 
Tyramide Signal Amplification reagent, Opal 570, for 15 minutes at room temperature, 
and then rinsed again (4x). 
Slides were incubated with ER Solution 1 for 20 minutes at 95 degrees Celsius to 
undergo antigen retrieval for the third primary antibody (GFAP), then rinsed in bond 
wash (x2) and incubated with 3% normal donkey serum in phosphate buffered saline and 
0.1% Triton X-100 (DKS Block) at room temperature for 30 minutes. Slides were 
incubated for 60 minutes at room temperature with the third primary antibody, Glial 
fibrillary acidic protein (chicken anti-GFAP, Abcam #ab106582, 1:2,000), diluted in 1% 
normal donkey serum in phosphate buffered saline and 0.1% Triton X-100, then rinsed 
again prior to incubation with a horseradish peroxidase (HRP)-conjugated chicken 
secondary antibody for 30 minutes at room temperature. Slides were rinsed (5x) and 
incubated with the third fluorescent Tyramide Signal Amplification reagent, Opal 650, 
for 15 minutes at room temperature.  
Following application of the third Opal dye, slides were rinsed and incubated with 
Spectral DAPI for 5 minutes at room temperature, followed by a final bond wash rinse 
marking the end of the “run”. Slides were removed from the Bond and transferred to Tris-
buffered saline with 0.1% Triton X-100. The tissue section on each slide was encircled 
using a hydrophobic pap pen and incubated with Sudan Black at room temperature for 15 
minutes. Slides were returned to TBST, briefly agitated, then rinsed (3x) with fresh 
solution. All slides were coverslipped using Prolong Gold Anti-Fade mounting media 
(Life Technologies) and stored at 4 degrees in an opaque slide folder.  
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Image Acquisition  
All slides were imaged using a Zeiss 880 laser scanning confocal microscope with 
a 10X objective using the Airyscan fast setting. Exposure and gain settings were 
determined using the field with the highest intensity fluorescence. All subsequent images 
were taken with the same settings. Resolution was determined using 2x Nyquist sampling 
followed by Airyscan processing (deconvolution) in Zen Black. Images were then 
transferred to Zen Blue to undergo stitching of the tile scan. 
 
Image Analysis 
Images were analyzed using the HALO image analysis software platform version 
2.1 (Indica Labs). Measures of global and perivascular AQP4 expression were quantified 
using an approach adapted from Zeppenfield (2017).  
To evaluate global AQP4 expression, the cortical grey matter ribbon on each slide 
was delineated using the Pen annotation tool in HALO in order to exclude underlying 
white matter from analysis. This cortical ribbon region of interest (ROI) was then 
subdivided into a grid of square tiles of uniform size (200ums) and reduced by 80% to 
generate tiles that represented a 20% random sampling of the image area (Figure 3). Any 
overt disruptions in tissue staining, for instance due to tissue folds or air bubbles, were 
excluded from the tiled partition analysis using the Exclusion Pen, represented by the 
dashed line in Figure 3. The mean fluorescent intensity of each tile on a slide was 
measured and averaged to determine the global AQP4 expression for each subject. 
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Figure 3. Quantification of Global AQP4 Expression. Overall “global” AQP4 
expression was determined for each case using the tiled partitioning tool in HALO to 
generate an analysis area representing random sampling of 20% of the cortical ribbon. 
Green=AQP4, Red=AT8, Magenta=GFAP. 
 
 
To evaluate perivascular AQP4 polarization, blood vessels classified as either 
lesional (AT8 positive) or non-lesional (AT8 negative) were encircled using the Pen 
annotation tool in HALO and concentrically partitioned to create a 4 micron-wide donut-
shaped ROI encompassing the perivascular space. The inner “donut hole” representing 
the vessel lumen was excluded from analysis. Five additional 40 micron-wide 
concentrically partitioned zones were generated from the original donut ROI in order to 
assess the distribution of AQP4 within 200 microns of each vessel (Figure 4). The mean 
fluorescent intensity of the 4 micron perivascular donuts was measured for each vessel 
and averaged across each vessel type (AT8-positive and AT8-negative) to quantify 
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lesional and non-lesional perivascular AQP4 expression for each subject. To assess 
perivascular AQP4 polarization, the ratio of the perivascular (“donut”) AQP4 expression 
to overall global AQP4 expression was calculated to generate a relative measurement of 
perivascular AQP4 localization for lesional and non-lesional vessels in each subject. 
 
     
Figure 4. Quantification of Perivascular AQP4 Distribution AQP4 polarization was 
measured for each vessel based on the ratio of mean AQP4 intensity within a 4µm-wide 
perivascular donut-shaped ROI spanning the perivascular space (PVS) to a subjects mean 
AQP4 global expression (“AQP4 Ratio, PVS:Parenchyma”). Five additional concentric 
zones (40 µms) were partitioned away from the PVS donut to aassess AQP4 distribution 
up to 200 microns away from the vessel.  
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Statistical Analysis  
  All statistical analyses were performed in GraphPad Prism (version 7). Within 
group comparison of lesional versus non-lesional AQP4 expression were calculated using 
paired t-tests. Between group comparison of CTE non-lesional vessels versus Control 
non-lesional vessels were determined using unpaired t-tests. Differences in AQP4 
expression between all three groups (CTE, Control, AD) were performed using either 
one-way ANOVAs for single variable comparisons, or mixed model two-way ANOVA 
with repeated measures to assess potential interactions between experimental groups and 
AQP4 expression across regions. 
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RESULTS 
 
Lesional Vessels are Associated with Increased Perivascular AQP4 Polarization in 
CTE  
Within CTE subjects, lesional blood vessels classified by the perivascular 
accumulation of p-tau (Figure 5) showed significantly higher perivascular AQP4 
polarization compared to non-lesional vessels (Figure 6A, *p<0.05, paired t-test). This 
pattern persisted even when CTE subjects were subdivided by CTE stage (early versus 
late) and age group (young versus old). These differences were significant within the late 
stage (Figure 6C, *p<0.05, paired t-test) and old (Figure 6D, *p<0.05, paired t-test) CTE 
groups, but did not reach statistical significance within the early (Figure 6B) or young 
(Figure 6D) CTE groups. 
 
Figure 5. Lesional CTE Vessel In this image the accumulation of p-tau (red) is 
associated with relatively high AQP4 (green) polarization around a blood vessel relative 
to the surrounding tissue characterized by high levels of astrocytosis (magenta).  
DAPI=blue. Measure bar scaled to 50 microns.  
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AQP4 Polarization in CTE Lesional versus CTE Non-Lesional Vessels  
 
 
           
    
    
 
Figure 6. Increased Perivascular AQP4 Polarization in CTE Lesional Vessels. CTE 
lesional vessels classified by the presence of p-tau pathology showed significantly higher 
perivascular AQP4 polarization compared to non-lesional vessels in the same subject (A, 
*p<0.05). This relationship was consistent when CTE subjects were broken down by age: 
young (B, no significance), and old (C, *p<0.05); and CTE Stage: early, defined as stages 
I-II (D, no significance), and late, defined as stages III-IV (E, *p<0.05).  
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CTE shows reduced perivascular AQP4 polarization around non-lesional vessels 
compared to Controls, but no difference in lesional vessels or overall global expression  
 The ratio of perivascular AQP4 polarization around non-lesional vessels in CTE 
appeared to be reduced relative to non-pathological controls without a history of 
repetitive head trauma, however this difference was not statistically significant (Figure 
7A). Meanwhile no differences were observed when comparing CTE lesional vessels to 
Control vessels (7B), or when assessing overall global AQP4 expression level between 
the two groups (7C).  
Comparison of AQP4 Expression in CTE and Controls 
           
 
Figure 7. No Significant Changes in AQP4 Expression in CTE versus Controls 
CTE showed no significant differences between controls when comparing non-lesional 
(7A) and lesional vessels (7B, *only non-lesional vessels available for analysis), as well 
as overall global AQP4 expression in the cortex. 
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 CTE shows non-significant increased perivascular AQP4 polarization around lesional 
vessels, but significantly less overall global AQP4 expression, compared to AD 
 When CTE subjects were compared to AD subjects, lesional vessels in CTE 
appeared to show higher perivascular AQP4 polarization (Figure 8B, p=0.1064, unpaired 
t-test) however these differences did not reach statistical significance. Yet when 
comparing global AQP4 expression, CTE had significantly less than AD (Figure 8C, 
*p<0.05, one-way ANOVA with multiple comparisons).  
 
Comparison of AQP4 Expression in CTE and AD 
    
     
Figure 8. CTE Has Lower Global AQP4 Expression Compared to AD. 
Perivascular AQP4 polarization in non-lesional vessels was no different between CTE 
and AD (8A), as well as for lesional vessels despite a trend towards higher polarization in 
CTE (8B). Meanwhile CTE showed significantly lower overall global AQP4 expression 
compared to AD (8C, *p<0.05).  
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DISCUSSION 
 
The findings reported in the current study indicate that CTE has increased, rather 
than decreased, perivascular AQP4 polarization around lesional vessels compared to non-
lesional vessels. Additional findings reported here suggest no significant changes in CTE 
non-lesional vessels compared to controls, and significantly less global AQP4 expression 
compared to AD. Better knowledge of astroglial AQP4 biology may help put these 
findings into context and shed light on their departure from prior studies.   
Cerebral edema refers to the build up of excess fluid in the extracellular 
(interstitial) or intracellular brain compartments causing the brain to swell. The most 
common causes of cerebral edema include injuries such as head trauma or stroke 
(Stokum et al., 2016). There are two main types of cerebral edema, cytotoxic and 
vasogenic, which differ in their onset following injury and their location within the brain. 
Despite these differences, the two types of edema are not considered to be mutually 
exclusive and are often found to co-exist (Rosenberg, 1999). 
The onset of cytotoxic edema is generally considered the first to occur following 
disruption of cellular metabolism and energy homeostasis in the acute phase after injury 
due to dysregulation of membrane channels and ion pumps that cause increased fluid 
uptake and astrocytic swelling (Stokum et al., 2016). Such events are known to trigger 
inflammatory processes that reduce the integrity of the neurovascular unit (NVU), thus 
setting the stage for BBB disruption and the subsequent development of vasogenic edema 
(Rosenberg, 1999).  Vasogenic edema is therefore associated with disruption of the 
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cerebrovasculature and the resulting extravasation of proteins and fluids from the blood 
vessels into the interstitium of the brain parenchyma (Stokum et al., 2016).  
AQP4 is considered a key player in both types of edema, however in different 
ways. For instance, perivascular AQP4 is thought to be detrimental in cytotoxic edema 
formation due to its role in cellular water uptake (Tang et al., 2016). In the setting of 
vasogenic edema, by contrast, increased perivascular AQP4 is thought be beneficial as it 
actively transports water out of the parenchyma, therefore reducing brain swelling (Li et 
al., 2011). Understanding of AQP4 biology and its bidirectional water transport 
capabilities thus helps explain the seemingly contradictory roles AQP4 plays in both the 
induction and resolution of different types of cerebral edema and may shed light on the 
findings reported here and in previous studies.    
Reduced acute edema formation and improved long-term functional outcomes in a 
juvenile murine model of TBI have been reported following inhibition of AQP4 
expression via injection of small-interfering RNA (Fukuda et al, 2013). The authors 
surmise that silencing of AQP4 expression led to reduced astrocytic water influx and 
reduced astrocytic swelling and osmotic stress following TBI, resulting in less 
perturbation of the neurovascular unit and thus less BBB disruption. Down regulation of 
AQP4 may therefore be beneficial in the acute phase immediately following TBI as it 
appears to reduce cytotoxic edema and its associated neurological insults. Meanwhile 
increased AQP4 expression acutely after injury would serve to increase brain swelling. 
The disruption of ion homeostasis and resulting energy crisis that ensues 
following a brain injury likely triggers the initial cascade of events leading to increased 
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fluid uptake and cytoxic edema (Giza et al., 2014). In response, astrocytes down regulate 
AQP4 expression in their perivascular endfeet to reduce fluid uptake and mitigate 
intracellular swelling (Stokum et al., 2016). Depending on the degree of the initial injury, 
the swelling is resolved overtime and astrocytic AQP4 polarization returns to baseline 
(Wang et al., 2012).  
Studies by Iliff and others reporting reduced perivascular AQP4 polarization 
following TBI in mice may therefore reflect a compensatory action of astroglia in the 
face of cytotoxic edema. However, such studies do not rule out the possibility that such 
AQP4 mislocalization would either a) not return baseline at a later time point not 
assessed in these studies, or b) not eventually give way to vasogenic edema in the long 
term due to secondary deleterious effects of AQP4 mislocalization at the neurovascular 
unit, ultimately leading to its repolarization.  
There are several possible reasons for the apparent discrepancies between the 
findings reported here and those of earlier studies, such as differences in the model used 
(animal versus human) and pathological process examined (AD versus aging versus TBI). 
Furthermore, within studies assessing the effect of TBI, the type (mild versus moderate 
versus severe) and frequency (single versus repetitive) of injury, as well as the time 
points at which data was collected (e.g. days versus weeks versus months versus years 
following injury), are all important variables that must be taken into consideration when 
interpreting and comparing results across studies. 
 It is especially important to point out for the purposes of the current study that 
previous groups examining post-traumatic AQP4 expression deliberately excluded areas 
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of brain tissue within the immediate vicinity of the impact site in order to avoid areas of 
intense reactive astrocytosis from their analyses (Ren et al., 2013, Iliff et al., 2014). Such 
exclusion areas were not implemented in the current study, and were most likely 
unavoidable given the inherently inflammatory environment surrounding lesioned vessels 
in CTE (Cherry et al., 2016).  
The findings reported by Zeppenfield et al. may be the most relevant for the 
purposes of the present study considering it was also a retrospective analysis using post-
mortem human brain tissue (2017). Nevertheless, important differences remain. For 
example, Zeppenfield was investigating the effect of age and AD on AQP4 localization, 
while the current study focused on its association with head trauma. The separate 
pathological processes examined in these two studies likely underlies the discrepancy in 
the results obtained.      
It is possible that astrocytes adopt a different AQP4 phenotype overtime in 
response to sustained exposure to repetitive mild head trauma. Although unproven, it 
seems possible that protracted AQP4 depolarization in the setting of repeated head 
impacts leads to prolonged disruption of astrocyte-endothelial cell interactions at the 
level of the NVU and ultimately reduced blood brain barrier integrity (Stokum et al., 
2016). The delayed onset of vasogenic edema induced by BBB breakdown may then 
stimulate astrocytic upregulation of AQP4 expression in their perivascular endfeet in 
order to facilitate the efflux of excess fluid and solutes in the extracellular space.    
From this perspective, the unexpected increase in perivascular AQP4 polarization 
around lesional vessels compared to non-lesional vessels detected in CTE may not be as 
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surprising as initially thought. Instead, these findings may reflect an additional 
compensatory mechanism of astrocytes in response to secondary vasogenic edema, rather 
than primary cytotoxic edema, which is likely the main driver of AQP4 depolarization 
reported in previous studies.  
In contrast to the between-subject comparisons discussed above, most of the 
between-group comparisons in the present study assessing potential differences between 
CTE and controls and CTE and AD subjects are difficult to interpret due to their lack of 
statistical significance. Nevertheless, if the reduced AQP4 polarization in CTE non-
lesional vessels compared to controls is found to be statistically significant in future 
studies with larger sample sizes, it will be important to rule out potential effects of 
vascular burden and other age-related variables considering the average age of the control 
subjects is significantly older than the CTE cohort.  
 The significant decrease in global AQP4 expression and a non-significant increase 
in perivascular AQP4 polarization between CTE and AD lesional vessels may be 
attributable to degree of reactive astrocytosis and Aβ plaque burden co-morbidly present 
in the tissue sampled. Previous studies suggest reactive astrocytes have increased AQP4 
expression in the presence of Aβ plaque pathology (Hoshi et al., 2012). Thus, considering 
that AD brains have significantly higher Aβ deposition compared to CTE (McKee et al., 
2013), this may explain why AD brains show increased AQP4 expression throughout the 
brain including reduced polarization at cerebral vessels compared to CTE.  It will be 
important for future studies to quantify marker of co-morbid pathologies, such as Aβ, in 
order to assess their potential interactions with AQP4 expression and localization.  
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In conclusion, the findings reported here indicate increased perivascular AQP4 
polarization around lesional vessels compared to non-lesional vessels in CTE. Such 
changes may reflect a delayed compensatory mechanism of astrocytic AQP4 regulation 
in response to secondary vasogenic edema driven by chronic inflammation and 
disrupted BBB integrity induced by sustained exposure to repetitive mild head trauma. 
 
Limitations of the current study 
The current study was limited by the small number of cases assessed, most 
notably in the AD and Control groups. In addition, the retrospective nature and use of 
post-mortem tissue means that all findings reported should be viewed as associative, 
rather than mechanistic, relationships. 
 
 
Future directions 
 
The findings reported here suggesting altered AQP4 polarization around 
perivascular lesions in CTE warrant further investigation. The limitations of the current 
study can be readily addressed in future studies by increasing the sample size of each 
group and including additional statistical analyses to control for the effect of age. It will 
also be important to incorporate additional histological markers for the 
cerebrovasculature to discriminate between vessels of different types (e.g. veins versus 
arteries) and sizes (e.g. arterioles versus capillaries). Future studies should also take extra 
steps to quantify GFAP in order to examine potential effects or interactions of 
astrocytosis on AQP4 expression in these cases. 
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3/2108                     Brain Health Fair, Museum of Science, Boston, MA 
5/2017              Science Fair Judge, Massachusetts Institute of Technology, 
Cambridge, MA 
4/2017          Cambridge Science Festival, Cambridge, MA 
3/2017          Lincoln School Science Night, Brookline, MA 
3/2017 S.E.T. in the City, Boston Area Girls’ STEM Collaborative, Boston,  
MA 
2/2017                     AAAS Family Science Day, Boston, MA 
5/2012 Dr. Jill Bolte Taylor’s “Brain Extravaganza” Project, Bloomington,   
IN 
  
 
CURRENT MEMBERSHIPS 
    
American Association of Anatomists 
 
 
SCIENTIFIC SKILLS  
 
Bench: immunofluorescence, immunohistochemistry, microtome and cryostat tissue 
sectioning, conventional and confocal microscopy, data analysis, scientific writing and 
communication  
 
Software: HALO, SPSS, GraphPad Prism, ImageJ, ZEN, Aperio Webscope, GingerALE 
 
 
 
